GSK PLC-SPON ADR (GSK) Institutional Shareholders

GSK PLC-SPON ADR (GSK) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $18.02B in GSK holdings during the latest filing period.

Fmr Llc is currently the largest disclosed institutional shareholder of GSK tracked by InsiderSet, reporting ownership valued at approximately $3.41B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $3.27B, representing an estimated loss of -4.06% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed GSK value among the investors covered in this analysis. Major shareholders include Fmr Llc, Dodge & Cox Stock Fund, Fisher Asset Management, Llc, and several other long-term asset managers with concentrated positions in GSK PLC-SPON ADR (GSK).

This page ranks the largest institutional GSK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

1,020

Total Reported Value

$18.02B

Largest Holder

Fmr Llc

Largest Position

$3.41B

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

56

Funds Exiting Positions

1

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.15%64,961,641$3,405,289,251$3,266,920,926-$138,368,325-4.06%
Dodge & Cox Stock FundV. D. Dodge, E. M. Cox1.32%48,197,514$2,526,513,684$2,423,852,979-$102,660,705-4.06%
Fisher Asset Management, Llc0.56%35,722,792$1,872,588,820$1,796,499,210-$76,089,610-4.06%
Primecap Management Co/Ca/0.78%25,182,068$1,320,044,006$1,266,406,200-$53,637,806-4.06%
Wellington Management Group Llp0.10%11,396,249$597,391,372$573,117,362-$24,274,010-4.06%
Jtc Employer Solutions Trustee Ltd36.11%8,592,987$450,315,000$432,141,316-$18,173,684-4.04%
Morgan Stanley0.02%7,657,562$401,409,572$385,098,793-$16,310,779-4.06%
Royal Bank Of Canada0.07%7,588,928$397,813,000$381,647,189-$16,165,811-4.06%
Price T Rowe Associates Inc0.04%6,923,642$362,938,000$348,189,956-$14,748,044-4.06%
Acadian Asset Management Llc0.41%6,660,434$349,109,000$334,953,226-$14,155,774-4.05%
Goldman Sachs Group Inc0.04%6,371,442$333,990,989$320,419,818-$13,571,171-4.06%
State Street Corp0.01%5,959,115$315,143,229$299,683,893-$15,459,336-4.91%
Mondrian Investment Partners Ltd3.97%4,910,830$257,425,685$246,965,641-$10,460,044-4.06%
Bank Of Montreal0.08%4,042,863$211,926,879$203,315,580-$8,611,299-4.06%
Blackrock, Inc.0.00%3,620,294$189,775,819$182,064,585-$7,711,234-4.06%
Grantham, Mayo, Van Otterloo & Co. Llc0.43%3,599,521$188,686,891$181,019,911-$7,666,980-4.06%
Hotchkis & Wiley Capital Management Llc0.52%3,413,574$178,939,549$171,668,636-$7,270,913-4.06%
Equity Investment Corp3.27%3,269,765$171,401,067$164,436,482-$6,964,585-4.06%
Ubs Group Ag0.02%2,806,205$147,101,266$141,124,049-$5,977,217-4.06%
Connor, Clark & Lunn Investment Management Ltd.0.27%2,767,591$145,077,121$139,182,151-$5,894,970-4.06%
Dimensional Fund Advisors Lp0.03%2,691,698$141,098,816$135,365,492-$5,733,324-4.06%
Point72 Asset Management, L.P.0.21%2,652,881$139,064,022$133,413,385-$5,650,637-4.06%
Bank Of America Corp0.01%2,216,888$116,209,277$111,487,298-$4,721,979-4.06%
Jpmorgan Chase & Co0.01%2,085,014$110,109,683$104,855,354-$5,254,329-4.77%
Envestnet Asset Management Inc0.02%1,908,549$100,044,669$95,980,929-$4,063,740-4.06%
Manufacturers Life Insurance Company, The0.08%1,887,739$98,955,252$94,934,394-$4,020,858-4.06%
American Century Companies Inc0.04%1,838,479$96,373,069$92,457,109-$3,915,960-4.06%
Northern Trust Corp0.01%1,754,564$91,974,245$88,237,024-$3,737,221-4.06%
Arrowstreet Capital, Limited Partnership0.04%1,633,029$85,603,380$82,125,028-$3,478,352-4.06%
Letko, Brosseau & Associates Inc1.26%1,624,668$85,165,097$81,704,554-$3,460,543-4.06%
Brandes Investment Partners, Lp0.55%1,483,198$77,750,479$74,590,027-$3,160,452-4.06%
Aristotle Capital Management, Llc0.16%1,463,518$76,719,824$73,600,320-$3,119,504-4.07%
Raymond James Financial Inc0.02%1,396,694$73,214,731$70,239,741-$2,974,990-4.06%
Wells Fargo & Company/Mn0.01%1,361,227$71,355,523$68,456,106-$2,899,417-4.06%
Bnp Paribas Financial Markets0.04%1,313,691$68,863,682$66,065,520-$2,798,162-4.06%
Mariner, Llc0.07%1,285,362$67,379,475$64,640,855-$2,738,620-4.06%
Sei Investments Co0.06%1,250,431$65,547,932$62,884,175-$2,663,757-4.06%
Miller Howard Investments Inc1.64%1,182,068$61,963,990$59,446,200-$2,517,790-4.06%
Qube Research & Technologies Ltd0.06%1,078,767$56,548,966$54,251,192-$2,297,774-4.06%
Russell Investments Group, Ltd.0.05%1,038,101$54,417,237$52,206,099-$2,211,138-4.06%
D. E. Shaw & Co., Inc.0.03%1,019,449$53,439,517$51,268,090-$2,171,427-4.06%
Lmr Partners Llp0.38%980,479$51,396,709$49,308,289-$2,088,420-4.06%
Callodine Capital Management, Lp3.38%979,740$51,357,971$49,271,125-$2,086,846-4.06%
Newedge Advisors, Llc0.15%953,574$49,986,404$47,955,236-$2,031,168-4.06%
Douglas Lane & Associates, Llc0.67%946,636$49,622,666$47,606,324-$2,016,342-4.06%
Lpl Financial Llc0.01%917,107$48,074,726$46,121,311-$1,953,415-4.06%
Bi Asset Management Fondsmaeglerselskab A/S0.38%911,826$47,798,000$45,855,730-$1,942,270-4.06%
Bank Of New York Mellon Corp0.01%838,769$43,968,305$42,181,693-$1,786,612-4.06%
Van Eck Associates Corp0.03%787,508$41,281,169$39,603,777-$1,677,392-4.06%
Stifel Financial Corp0.03%642,212$33,664,786$32,296,841-$1,367,945-4.06%
Showing 50 of 1,020

Frequently asked questions about GSK

  • Who owns the most GSK stock?

    The largest holders of GSK are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for GSK PLC-SPON ADR (GSK).

  • Is GSK widely held by superinvestors?

    Many widely followed stocks like GSK appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GSK is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.